title: Ikaros silences T-bet expression and interferon-gamma production during T helper 2 differentiation.
abstract: CD4+ T cells can be instructed by nonantigen-specific signals to differentiate into functionally distinct lineages with mutually exclusive patterns of cytokine production. The molecular events that drive interferon-gamma (IFN gamma) production during Th1 development are well understood, but mechanisms that silence this cytokine during Th2 polarization are not clear. In this study, we find that the tbx21 gene encoding the Th1 master regulator T-bet is a direct target of the transcriptional repressor Ikaros. In Th2 cells, which do not express T-bet, strong Ikaros binding could be detected at the endogenous tbx21 promoter, whereas this gene was not occupied by Ikaros in T-bet-expressing Th1 cells. Inhibition of Ikaros DNA binding activity during Th2 polarization resulted in loss of Ikaros promoter occupancy, increased T-bet expression, and inappropriate T-bet-dependent production of IFN gamma. Ikaros was also required for epigenetic imprinting of the ifn gamma locus during Th2 polarization, and loss of Ikaros function in vivo led to an inappropriate Th1 response to the parasite Shistosoma mansoni. These studies demonstrate that Ikaros, a factor with an established role in lymphocyte development, also regulates the development of peripheral T helper responses.
authors.affiliation: Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine and The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA.
authors.forename: Rajan M
authors.initials: RM
authors.lastname: Thomas
authors.forename: Chunxia
authors.initials: C
authors.lastname: Chen
authors.forename: Neelanjana
authors.initials: N
authors.lastname: Chunder
authors.forename: Lingzhi
authors.initials: L
authors.lastname: Ma
authors.forename: Justin
authors.initials: J
authors.lastname: Taylor
authors.forename: Edward J
authors.initials: EJ
authors.lastname: Pearce
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Wells
mesh_terms: D056704:Adaptive Immunity / Q000235:genetics / Q000276:immunology; D000818:Animals; D002454:Cell Differentiation / Q000502:physiology; D002478:Cells, Cultured; D019175:DNA Methylation / Q000276:immunology; D044127:Epigenesis, Genetic / Q000276:immunology; D015870:Gene Expression / Q000276:immunology; D020868:Gene Silencing / Q000276:immunology; D018392:Genomic Imprinting / Q000502:physiology; D051740:Ikaros Transcription Factor / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D007371:Interferon-gamma / Q000096:biosynthesis / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D012555:Schistosomiasis mansoni / Q000276:immunology; D020825:T-Box Domain Proteins / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D018417:Th1 Cells / Q000166:cytology / Q000469:parasitology / Q000502:physiology; D018418:Th2 Cells / Q000166:cytology* / Q000469:parasitology / Q000502:physiology*; D000098815:T-bet Transcription Factor
chemical_list: D020825:T-Box Domain Proteins; D000098815:T-bet Transcription Factor; C497238:Zfpn1a1 protein, mouse; D051740:Ikaros Transcription Factor; D007371:Interferon-gamma